These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 7906993
21. Deletion mapping in human renal cell carcinoma. Bergerheim U, Nordenskjöld M, Collins VP. Cancer Res; 1989 Mar 15; 49(6):1390-6. PubMed ID: 2924296 [Abstract] [Full Text] [Related]
22. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas. Kardas I, Mrózek K, Babinska M, Krajka K, Hadaczek P, Lubinski J, Roszkiewicz A, Kuziemska E, Limon J. Oncol Rep; 2005 May 15; 13(5):949-56. PubMed ID: 15809763 [Abstract] [Full Text] [Related]
23. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Anglard P, Tory K, Brauch H, Weiss GH, Latif F, Merino MJ, Lerman MI, Zbar B, Linehan WM. Cancer Res; 1991 Feb 15; 51(4):1071-7. PubMed ID: 1671754 [Abstract] [Full Text] [Related]
24. Two regions of homozygosity on chromosome 3p in squamous cell carcinoma of the head and neck: comparison with cytogenetic analysis. Buchhagen DL, Worsham MJ, Dyke DL, Carey TE. Head Neck; 1996 Feb 15; 18(6):529-37. PubMed ID: 8902566 [Abstract] [Full Text] [Related]
25. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas. Bugert P, Wilhelm M, Kovacs G. Genes Chromosomes Cancer; 1997 Sep 15; 20(1):9-15. PubMed ID: 9290948 [Abstract] [Full Text] [Related]
26. Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma. Morita R, Saito S, Ishikawa J, Ogawa O, Yoshida O, Yamakawa K, Nakamura Y. Cancer Res; 1991 Nov 01; 51(21):5817-20. PubMed ID: 1682036 [Abstract] [Full Text] [Related]
27. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM. Cancer Res; 1993 Jul 01; 53(13):3092-7. PubMed ID: 8319216 [Abstract] [Full Text] [Related]
28. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung. Yokoyama S, Yamakawa K, Tsuchiya E, Murata M, Sakiyama S, Nakamura Y. Cancer Res; 1992 Feb 15; 52(4):873-7. PubMed ID: 1346586 [Abstract] [Full Text] [Related]
29. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas. Jones TD, Eble JN, Wang M, MacLennan GT, Delahunt B, Brunelli M, Martignoni G, Lopez-Beltran A, Bonsib SM, Ulbright TM, Zhang S, Nigro K, Cheng L. Clin Cancer Res; 2005 Oct 15; 11(20):7226-33. PubMed ID: 16243792 [Abstract] [Full Text] [Related]
30. Loss of 14q31-q32.2 in renal cell carcinoma is associated with high malignancy grade and poor survival. Alimov A, Sundelin B, Wang N, Larsson C, Bergerheim U. Int J Oncol; 2004 Jul 15; 25(1):179-85. PubMed ID: 15202004 [Abstract] [Full Text] [Related]
31. Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma. Schraml P, Müller D, Bednar R, Gasser T, Sauter G, Mihatsch MJ, Moch H. J Pathol; 2000 Mar 15; 190(4):457-61. PubMed ID: 10699995 [Abstract] [Full Text] [Related]
32. Deletion of two separate regions on chromosome 3p in breast cancers. Chen LC, Matsumura K, Deng G, Kurisu W, Ljung BM, Lerman MI, Waldman FM, Smith HS. Cancer Res; 1994 Jun 01; 54(11):3021-4. PubMed ID: 7910519 [Abstract] [Full Text] [Related]
33. Terminal deletion of chromosome 3p sequences in nonpapillary renal cell carcinomas: a breakpoint cluster between loci D3S1285 and D3S1603. Wilhelm M, Bugert P, Kenck C, Staehler G, Kovacs G. Cancer Res; 1995 Nov 15; 55(22):5383-5. PubMed ID: 7585605 [Abstract] [Full Text] [Related]
34. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. Fullwood P, Marchini S, Rader JS, Martinez A, Macartney D, Broggini M, Morelli C, Barbanti-Brodano G, Maher ER, Latif F. Cancer Res; 1999 Sep 15; 59(18):4662-7. PubMed ID: 10493522 [Abstract] [Full Text] [Related]
35. Multiple genetic alterations in small-cell lung carcinoma. Yokota J, Mori N, Akiyama T, Shimosato Y, Sugimura T, Terada M. Princess Takamatsu Symp; 1989 Sep 15; 20():43-8. PubMed ID: 2577337 [Abstract] [Full Text] [Related]
36. Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis. van den Berg A, Hulsbeek MF, de Jong D, Kok K, Veldhuis PM, Roche J, Buys CH. Genes Chromosomes Cancer; 1996 Jan 15; 15(1):64-72. PubMed ID: 8824727 [Abstract] [Full Text] [Related]
37. Detection of 17p loss in gastric carcinoma using polymerase chain reaction. Kim CJ, Kim WH, Kim CW, Lee JB, Lee CK, Kim YL. Lab Invest; 1995 Feb 15; 72(2):232-6. PubMed ID: 7853854 [Abstract] [Full Text] [Related]
38. Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma. Alimov A, Kost-Alimova M, Liu J, Li C, Bergerheim U, Imreh S, Klein G, Zabarovsky ER. Oncogene; 2000 Mar 09; 19(11):1392-9. PubMed ID: 10723130 [Abstract] [Full Text] [Related]
39. Deletion mapping of chromosome 3p in human uterine cervical cancer. Kohno T, Takayama H, Hamaguchi M, Takano H, Yamaguchi N, Tsuda H, Hirohashi S, Vissing H, Shimizu M, Oshimura M. Oncogene; 1993 Jul 09; 8(7):1825-32. PubMed ID: 8099726 [Abstract] [Full Text] [Related]
40. Loss of heterozygosity at the familial RCC t(3;8) locus in most clear cell renal carcinomas. Druck T, Kastury K, Hadaczek P, Podolski J, Toloczko A, Sikorski A, Ohta M, LaForgia S, Lasota J, McCue P. Cancer Res; 1995 Nov 15; 55(22):5348-53. PubMed ID: 7585599 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]